C
Cylera
Focused on protecting healthcare devices from cyber attacks
About Cylera
Cylera is a cybersecurity company founded by Timur Ozekcin and Paul Bakoyiannis.
Ozekcin's background in a prior medical device venture, Heuristics Health, provided the foundational insight for Cylera's mission. This experience highlighted the increasing security risks associated with the proliferation of connected devices in healthcare.
Cylera's core business is providing a cybersecurity platform specifically designed for the healthcare Internet of Things (IoT). The company serves healthcare organizations, from hospitals to clinics, that are managing a growing number of connected medical and IoT devices. The business model is primarily software-as-a-service (SaaS), offering subscriptions to its platform.
The platform addresses the critical need to protect patient data, ensure the operational continuity of medical devices, and comply with regulatory requirements. It works by creating a comprehensive inventory of all connected assets within a healthcare network. For each device, it conducts a detailed risk analysis, identifying vulnerabilities and potential threats. The system provides real-time threat detection and offers actionable steps for mitigation, helping to prevent security breaches. This includes monitoring for anomalous behavior and unauthorized access, thereby safeguarding the entire healthcare delivery environment.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- New York City, United States
- Employees
- 38
- Open positions
- None listed
- Dealroom signal
- 82.7/100
- Industry
- Health, Security
- Sub-industry
- Medical Devices, Device security & Antivirus
- Sector
- Health Tech & Medtech, Patient Care, Cybersecurity, Hard Tech, Health It
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BEquity / VC | Jan 2023 | $26M | $104M | Litquidity · Channel Angels · Contour Venture Partners | — |
| CONVERTIBLEEquity / VC | Mar 2022 | $0 | — | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Cylera is 1.8K monthly website visits, up 0% over the last three months. Cylera's team grew 5.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
Maverick Ventures
Samsung Next
Two Sigma Ventures
Contour Venture Partners
Great Oaks Venture Capital
Dreamit Ventures
Red Bear Angels
Concord Health Partners
Series A2 investors entered at this stage
Litquidity
Channel Angels
Other known investors4 additional known investors
Alumni Ventures
Epsilon Health Investors
Rho Capital Partners- TVTech Council Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cylera on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cylera’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.